Sone-296 May 2026
Key figures to include
| Property | Data (if available) | |----------|---------------------| | Molecular formula / weight | | | Key functional groups / scaffold | | | In‑vitro potency (IC₅₀, EC₅₀) | | | Selectivity panel (off‑target kinases, receptors) | | | ADME (solubility, permeability, metabolic stability) | | | PK in rodents (Cmax, half‑life, oral bioavailability) | | | Safety window (hERG, CYP inhibition) | | SONE-296
Discussion points
Suggested sources